MicroCT and contrast-enhanced microCT to study the in vivo degradation behavior and biocompatibility of candidate metallic intravascular stent materials
Source abstract
Abstract
Biodegradable intravascular stents offer a promising alternative to permanent stents for treating atherosclerosis-related artery narrowing by potentially avoiding long-term complications. Identifying materials that degrade harmlessly and uniformly at a suitable rate is crucial. This study evaluated an advanced zinc alloy (Zn-Ag-Cu-Mn-Zr) alongside pure iron and pure zinc, using a simplified stent model of metallic wires implanted in the rat aorta. Assessments were made at 7, 24, and 84 days post-implantation using X-ray microfocus computed tomography (microCT) and contrast-enhanced microCT (CECT). For CECT, a contrast agent was chosen to provide optimal soft tissue contrast and minimal interaction with the wires. This combination of imaging techniques allowed us to evaluate degradation behavior, compare volume loss in various locations (outside the arterial lumen, inside the lumen, and encapsulated by neointima), compute degradation rates, and evaluate neointima tissue formation. Results showed that zinc and its alloy degrade less uniformly than iron, which demonstrates uniform surface degradation. The zinc alloy had a higher initial volume loss than the other materials but showed little increase over time. Neointima formation was similar for zinc and the zinc alloy, while iron provoked less tissue formation than both zinc and the reference cobalt-chromium alloy. Additionally, unlike cobalt-chromium and zinc, iron wires did not achieve consistent tissue encapsulation along their entire length, which may impair their performance. Mild inflammation was noted around zinc-based implants. Combining microCT and CECT provided 3D information on degradation uniformity, degradation products, and neointima morphometrics, highlighting the power of these imaging techniques to evaluate implant materials in a highly accurate way compared to previous 2D methods. STATEMENT OF SIGNIFICANCE: Biodegradable intravascular stents offer a promising solution to long-term complications associated with permanent stents by gradually dissolving in the body. To evaluate a novel zinc alloy (Zn-Ag-Cu-Mn-Zr) with improved mechanical properties, microstructure, and biocompatibility, we compared it to pure iron and zinc. We used advanced 3D imaging techniques, i.e., microCT and contrast-enhanced microCT, to assess the degradation behavior and the tissue response in a rat aorta model. The zinc alloy demonstrated promising properties despite less uniform degradation and mild inflammation compared to iron. Our findings highlight the superiority of 3D imaging over previously used 2D techniques in evaluating stent materials, offering critical insights into degradation processes and biocompatibility. These highly accurate measurements provide crucial information for developing improved biodegradable implants.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Corrosion Behavior and Inhibition · Metal and Thin Film Mechanics · Magnesium Alloys: Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. World Health Organization, Cardiovascular diseases (CVDs), (2021). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed December 31, 2023).
2. Novel high-strength, low-alloys Zn-Mg (< 0.1 wt% Mg) and their arterial biodegradation10.1016/j.msec.2017.11.021 ↗
3. P.K. Bowen, E.R. Shearier, S. Zhao, R.J. Guillory, F. Zhao, J. Goldman, J.W. Drelich, Biodegradable metals for cardiovascular stents: from clinical concerns to recent zn-alloys, Adv. Healthc. Mater. 5 (2016) 1121–1140. https://doi.org/10.1002/adhm.201501019.10.1002/adhm.201501019 ↗
4. Towards revealing key factors in mechanical instability of bioabsorbable Zn-based alloys for intended vascular stenting10.1016/j.actbio.2020.01.028 ↗
5. Recent advances and directions in the development of bioresorbable metallic cardiovascular stents: Insights from recent human and in vivo studies10.1016/j.actbio.2021.03.058 ↗
6. Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents10.1002/adma.201300226 ↗
7. Evaluation of wrought Zn–Al alloys (1, 3, and 5 wt % Al) through mechanical and in vivo testing for stent applications10.1002/jbm.b.33850 ↗
8. Corrosion behavior and biocompatibility evaluation of a novel zinc-based alloy stent in rabbit carotid artery model10.1002/jbm.b.34274 ↗
9. Fluid-induced corrosion behavior of degradable zinc for stent application10.1016/j.jmst.2021.02.050 ↗
10. Long-term surveillance of zinc implant in murine artery: Surprisingly steady biocorrosion rate10.1016/j.actbio.2017.05.045 ↗
11. Advances in the development of biodegradable coronary stents: A translational perspective
12. Biodegradable iron-based materials—what was done and what more can be done?10.3390/ma14123381 ↗
13. Mg-based bulk metallic glasses for biodegradable implant materials: A review on glass forming ability, mechanical properties, and biocompatibility10.1016/j.jnoncrysol.2015.07.018 ↗
14. Fundamentals and advances in magnesium alloy corrosion10.1016/j.pmatsci.2017.04.011 ↗
15. Are Fe-based stenting materials biocompatible? A critical review of in vitro and in vivo studies
16. Recent research and progress of biodegradable zinc alloys and composites for biomedical applications: biomechanical and biocorrosion perspectives
17. Zn-Li alloy after extrusion and drawing: structural, mechanical characterization, and biodegradation in abdominal aorta of rat10.1016/j.msec.2017.02.167 ↗
18. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta10.1016/j.biomaterials.2006.05.029 ↗
19. A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials10.1002/jbm.b.31922 ↗
20. Evolution of metallic cardiovascular stent materials: A comparative study among stainless steel, magnesium and zinc10.1016/j.biomaterials.2019.119641 ↗
21. Analysis of Vascular Inflammation against Bioresorbable Zn-Ag-Based Alloys10.1021/acsabm.0c00740 ↗
22. R.J. Guillory II, M. Sikora-Jasinska, J.W. Drelich, J. Goldman, In Vitro Corrosion and in Vivo Response to Zinc Implants with Electropolished and Anodized Surfaces, ACS. Appl. Mater. Interfaces. 11 (2019) 19884–19893. https://doi.org/10.1021/acsami.9b05370.10.1021/acsami.9b05370 ↗
23. R.J. Guillory II, A.A. Oliver, E. Davis, E.J. Earley, W. Jaroslaw, J. Goldman, Preclinical In-Vivo Evaluation and Screening of Zinc Based Degradable Metals for Endovascular Stents, 71 (2021) 1436–1446. https://doi.org/10.1007/s11837-019-03371-5.Preclinical.10.1007/s11837-019-03371-5 ↗
24. Improved biocompatibility of Zn–Ag-based stent materials by microstructure refinement10.1016/j.actbio.2022.03.047 ↗
25. Characterization and in vivo evaluation of a bio-corrodible nitrided iron stent10.1007/s10856-012-4823-z ↗
26. Short-term safety and efficacy of the biodegradable iron stent in mini-swine coronary arteries10.3760/cma.j.issn.0366-6999.20131120 ↗
27. In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications10.1002/jbm.b.33234 ↗
28. Short-term effects of biocorrodible iron stents in porcine coronary arteries10.1111/j.1540-8183.2007.00319.x ↗
29. Long-term in vivo corrosion behavior, biocompatibility and bioresorption mechanism of a bioresorbable nitrided iron scaffold10.1016/j.actbio.2017.03.020 ↗
30. Long-term in vivo study of biodegradable Zn-Cu stent: A 2-year implantation evaluation in porcine coronary artery10.1016/j.actbio.2019.08.012 ↗
31. M.S. Dargusch, J. Venezuela, A. Dehghan-Manshadi, S. Johnston, N. Yang, K. Mardon, C. Lau, R. Allavena, In Vivo Evaluation of Bioabsorbable Fe-35Mn-1Ag: First Reports on In Vivo Hydrogen Gas Evolution in Fe-Based Implants, Adv. Healthc. Mater. 10 (2021) 1–15. https://doi.org/10.1002/adhm.202000667.10.1002/adhm.202000667 ↗
32. Evaluation of in vitro and in vivo biocompatibility of iron produced by powder metallurgy10.1016/j.msec.2020.111129 ↗
33. Ex vivo blood vessel bioreactor for analysis of the biodegradation of magnesium stent models with and without vessel wall integration10.1016/j.actbio.2016.12.039 ↗
34. Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model10.1016/j.biomaterials.2017.08.022 ↗
35. Development of biodegradable Zn-1X binary alloys with nutrient alloying elements Mg
36. Exploring the biodegradability of candidate metallic intravascular stent materials using X-ray microfocus computed tomography: An in vitro study
37. Early Alterations of Intra-Mural Elastic Lamellae Revealed by Synchrotron X-ray Micro-CT Exploration of Diabetic Aortas10.3390/ijms23063250 ↗
38. Sub-micrometer morphology of human atherosclerotic plaque revealed by synchrotron radiation-based μCT—A comparison with histology10.1371/journal.pone.0265598 ↗
39. A review of ex vivo x-ray microfocus computed tomography-based characterization of the cardiovascular system10.3390/ijms22063263 ↗
40. Contrast-enhanced microCT for virtual 3D anatomical pathology of biological tissues: A literature review10.1155/2019/8617406 ↗
41. A. Maes, C. Pestiaux, A. Marino, T. Balcaen, L. Leyssens, S. Vangrunderbeeck, G. Pyka, W.M. De Borggraeve, L. Bertrand, C. Beauloye, S. Horman, M. Wevers, G. Kerckhofs, Cryogenic Contrast-Enhanced MicroCT: a Nondestructive Approach to 3D Quantitative Histopathology of Soft Biological Tissues, Nat. Commun. 13 (2022). https://doi.org/10.1038/s41467-022-34048-4.10.1038/s41467-022-34048-4 ↗
42. A. Maes, Cryogenic contrast-enhanced microCT enables nondestructive 3D quantitative histopathology of soft biological tissues, Github (2020). https://doi.org/10.5281/zenodo.7034265.
43. Rapid 3D phenotyping of cardiovascular development in mouse embryos by micro-CT with iodine staining10.1161/CIRCIMAGING.109.918482 ↗
44. A Novel Method for In Vitro 3D Imaging of Dissecting Pressurized Arterial Segments Using X-Ray Microtomography
45. Non-destructive 3D characterization of the blood vessel wall microstructure in different species and blood vessel types using contrast-enhanced microCT and comparison with synthetic vascular grafts10.1016/j.actbio.2023.04.013 ↗
46. Volume shrinkage of bone, brain and muscle tissue in sample preparation for micro-CT and light sheet fluorescence microscopy (LSFM)10.1017/S1431927614001329 ↗
47. Reducing soft-tissue shrinkage artefacts caused by staining with Lugol's solution10.1038/s41598-021-99202-2 ↗
48. Guillory · 2019